Geert Cauwenbergh
2015
In 2015, Geert Cauwenbergh earned a total compensation of $625.9K as President, Chief Executive Officer and acting Chief Financial Officer at RXi Pharmaceuticals, a 22% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $190,000 |
|---|---|
| Option Awards | $37,240 |
| Salary | $398,361 |
| Other | $300 |
| Total | $625,901 |
Cauwenbergh received $398.4K in salary, accounting for 64% of the total pay in 2015.
Cauwenbergh also received $190K in non-equity incentive plan, $37.2K in option awards and $300 in other compensation.
Rankings
In 2015, Geert Cauwenbergh's compensation ranked 9,964th out of 13,638 executives tracked by ExecPay. In other words, Cauwenbergh earned more than 26.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,964 out of 13,638 | 27th |
Division Manufacturing | 3,806 out of 5,190 | 27th |
Major group Chemicals And Allied Products | 1,394 out of 1,854 | 25th |
Industry group Drugs | 1,143 out of 1,528 | 25th |
Industry Pharmaceutical Preparations | 896 out of 1,182 | 24th |
Source: SEC filing on April 27, 2017.
Cauwenbergh's colleagues
We found one more compensation record of an executive who worked with Geert Cauwenbergh at RXi Pharmaceuticals in 2015.
2015
Pamela Pavco
RXi Pharmaceuticals